Take control of insulin. Take control of the future. The U.S. insulin supply chain is vulnerable — dominated by three pharmaceutical giants and reliant on international components. In a post-COVID world where supply shocks and rising prices are the norm, millions of diabetics are left exposed. Blueprint for Diabetic Sovereignty offers a bold solution. This book is the first of its kind: a practical, step-by-step guide to building a U.S.-based insulin production facility using American resources, talent, and infrastructure. Written by a Type 1 diabetic with a background in business strategy and systems design, this book lays out everything an entrepreneur, investor, or health policy advocate needs to know to bring insulin production home — and put healthcare security into the hands of the people who need it most. Inside this book, you'll discover: How to source all essential insulin components domestically - A complete facility design and regulatory roadmap (including FDA and GMP compliance) - Cost models, funding strategies, and site selection breakdowns - Historical insights and future forecasts on the insulin market - Why domestic insulin production isn’t just possible — it’s essential Whether you’re a biotech visionary, a public health advocate, or a problem-solver looking to make real impact, this is more than a business manual — it’s a declaration of independence for American healthcare. Because America's healthcare security should be made in America. Part of the "Vital Supply Lines" series